Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google Scholar citation report
Citations : 352

Advances in Cancer Prevention received 352 citations as per Google Scholar report

Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Euro Pub
  • ICMJE
Share This Page

Oluwafemi Olawuyi

College of Graduate Health Studies, A.T. Still University, MO, USA

Biography

Oluwafemi Olawuyi, College of Graduate Health Studies, A.T. Still University, MO, USA,                                                                                                                          
Publications

Evaluation of Docetaxel vs. Tamoxifen in Combined Therapies Based on Overall Survival Rate (OSR) Endpoint among Female Breast Cancer Patients

In this review, overall survival rate (OSR) result and safety data were evaluated based on data from four clinical trials on combined therapies of Docetaxel and Tamoxifen among breast cancer patients, which were published in peer-reviewed journals. Data was extracted from single treatment trials of Docetaxel plus Cisplatin, and Tamoxifen plus Vorin... Read More»

Oluwafemi Olawuyi and Melanie Tidman

Review Article: Adv Cancer Prev 2: 122

DOI: 10.4172/2472-0429.1000122

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top